TY - JOUR
AU - C. Josephson
AU - A. Gonzalez-Izquierdo
AU - S. Denaxas
AU - T. Sajobi
AU - K. Klein
AU - S. Wiebe
AD - Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Alberta, Canada.
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada.
Hotchkiss Brain Institute, University of Calgary, Alberta, Canada.
O'Brien Institute for Public Health, University of Calgary, Alberta, Canada.
Centre for Health Informatics, University of Calgary, Alberta, Canada.
UCL Institute of Health Informatics, London, United Kingdom.
Health Data Research UK, London, United Kingdom.
Alan Turing Institute, London, United Kingdom.
Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Alberta, Canada.
Alberta Children's Hospital Research Institute, University of Calgary, Alberta, Canada.
Clinical Research Unit, Cumming School of Medicine, University of Calgary, Alberta, Canada.
AN - 37306981
BT - JAMA Neurol
C2 - PMC10262059 educational grants from UCB Pharma and Eisai for work unrelated to this project during the conduct of the study. Dr Klein reported receiving personal fees from UCB Pharma outside the submitted work and Novartis Pharma AG, Eisai, and GW Pharmaceuticals unrelated to this project and grants from the federal state of Hessen, Germany, through the LOEWE program and from the Canadian Institutes of Health Research for work unrelated to this project. Dr Wiebe reported receiving unrestricted educational grants to his institution from UCB Pharma and Eisai outside the submitted work. No other disclosures were reported.
DO - 10.1001/jamaneurol.2023.1580
DP - NLM
ET - 2023/06/12
LA - eng
N1 - 2168-6157
Josephson, Colin B
Gonzalez-Izquierdo, Arturo
Denaxas, Spiros
Sajobi, Tolulope T
Klein, Karl Martin
Wiebe, Samuel
Journal Article
United States
JAMA Neurol. 2023 Jun 12:e231580. doi: 10.1001/jamaneurol.2023.1580.
PY - 2023
SN - 2168-6149 (Print)
2168-6149
T2 - JAMA Neurol
TI - Independent Associations of Incident Epilepsy and Enzyme-Inducing and Non-Enzyme-Inducing Antiseizure Medications With the Development of Osteoporosis
ER -